Key takeaways:
- None of the individuals in the control group were able to pass all of the criteria-based return-to-play tests.
- There was a high failure rate, with an average of 47% of tests being passed by an individual.
NASHVILLE, Tenn. — Criteria-based return-to-play testing for patients undergoing arthroscopic Bankart Repair may not address baseline differences between patients, according to data presented here.
“There are baseline asymmetries for upper extremity and healthy patients,” Amit Momaya, MD, chief of sports medicine at the University of Alabama at Birmingham, told Healio about results presented at the American Orthopaedic Society for Sports Medicine Annual Meeting. “When we decide on who can return to play after an arthroscopic Bankart repair, we have to be mindful of these baseline differences, and use a whole collection of both objective criteria and various other criteria when making that decision.”
Data were derived from Momaya A, et al. Paper 9. Presented at: American Orthopaedic Society for Sports Medicine Annual Meeting; July 10-12, 2025; Nashville, Tenn.
According to the abstract, Momaya and colleagues prospectively collected data from a control group of 26 healthy volunteers (average age, 24.8 years; 53.8% men) without any history of upper extremity injury or surgery to analyze their outcomes with criteria-based return-to-play testing designed for patients who underwent arthroscopic Bankart repair.
Amit Momaya
Outcomes measured included isometric testing, isokinetic strength testingendurance testing, and functional testing via the closed kinetic chain upper extremity stability test and unilateral shot put test.
Overall, Momaya said none of the individuals in the healthy control group were able to pass all of the criteria-based return-to-play tests.
Momaya also said there was a high failure rate, with an average of 47% of tests being passed by an individual.
“A future direction for these studies would be to look at baseline asymmetries and if they are predictive of future shoulder instability,” Momaya said.
For more information:
Amit Momaya, MD, can be reached at amit.momaya@gmail.com.
Sources/Disclosures
Collapse
Momaya A, et al. Paper 9. Presented at: American Orthopaedic Society for Sports Medicine Annual Meeting; July 10-12, 2025; Nashville, Tenn.
Disclosures:
Momaya reports being on the editorial board for Arthroscopy; receiving consulting fees from ConMed and Miach Orthopaedics; and receiving equity in Convergence Medical and Reparel.
